<VariationArchive VariationID="1676233" VariationName="NM_000092.5(COL4A4):c.4760dup (p.Cys1588fs)" VariationType="Duplication" Accession="VCV001676233" Version="3" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-06-23" DateCreated="2022-04-12" MostRecentSubmission="2024-04-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1667644" VariationID="1676233">
      <GeneList>
        <Gene Symbol="COL4A4" FullName="collagen type IV alpha 4 chain" GeneID="1286" HGNC_ID="HGNC:2206" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2q36.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="226967360" stop="227164488" display_start="226967360" display_stop="227164488" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227867426" stop="228029274" display_start="227867426" display_stop="228029274" Strand="-" />
          </Location>
          <OMIM>120131</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000092.5(COL4A4):c.4760dup (p.Cys1588fs)</Name>
      <CanonicalSPDI>NC_000002.12:227008066:GGGGGG:GGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>2q36.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="227008066" stop="227008067" display_start="227008066" display_stop="227008067" variantLength="1" positionVCF="227008066" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="227872782" stop="227872783" display_start="227872782" display_stop="227872783" variantLength="1" positionVCF="227872782" referenceAlleleVCF="T" alternateAlleleVCF="TG" />
      </Location>
      <ProteinChange>C1588fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.227872788dup" Assembly="GRCh37">
            <Expression>NC_000002.11:g.227872788dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.227008072dup" Assembly="GRCh38">
            <Expression>NC_000002.12:g.227008072dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011592.1" sequenceAccession="NG_011592" sequenceVersion="1" change="g.161493dup">
            <Expression>NG_011592.1:g.161493dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000092.5" sequenceAccession="NM_000092" sequenceVersion="5" change="c.4760dup" MANESelect="true">
            <Expression>NM_000092.5:c.4760dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000083.3" sequenceAccession="NP_000083" sequenceVersion="3" change="p.Cys1588fs">
            <Expression>NP_000083.3:p.Cys1588fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_231" sequenceAccession="LRG_231">
            <Expression>LRG_231:g.161493dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_231t1" sequenceAccession="LRG_231t1">
            <Expression>LRG_231t1:c.4760dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000092.5" sequenceAccession="NM_000092" sequenceVersion="5" change="c.4760dupC" MANESelect="true">
            <Expression>NM_000092.5:c.4760dupC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1206142672" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000092.5(COL4A4):c.4760dup (p.Cys1588fs) AND Autosomal dominant Alport syndrome" Accession="RCV002221395" Version="3">
        <ClassifiedConditionList TraitSetID="5740">
          <ClassifiedCondition DB="MedGen" ID="C5882663">Autosomal dominant Alport syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-30" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000092.5(COL4A4):c.4760dup (p.Cys1588fs) AND not provided" Accession="RCV003738157" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-03-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-03-30" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2022-04-12" MostRecentSubmission="2024-04-15">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26809805</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30745910</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33772369</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301386</ID>
          <ID Source="BookShelf">NBK1207</ID>
        </Citation>
        <DescriptionHistory Dated="2024-02-17">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="5740" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="158" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Alport syndrome dominant type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Renal failure and sensorineural hearing loss</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Alport syndrome 3, autosomal dominant</ElementValue>
                <XRef ID="Alport+Syndrome+Dominant+Type/336" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Autosomal dominant Alport syndrome</ElementValue>
                <XRef ID="MONDO:0007086" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">ALPORT SYNDROME 3A, AUTOSOMAL DOMINANT</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">ATS3A</ElementValue>
                <XRef Type="MIM" ID="104200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">In Alport syndrome (AS) a spectrum of phenotypes ranging from progressive renal disease with extrarenal abnormalities to isolated hematuria with a non-progressive or very slowly progressive course is observed. Approximately two thirds of AS is X-linked (XLAS); approximately 15% is autosomal recessive (ARAS), and approximately 20% is autosomal dominant (ADAS). In the absence of treatment, renal disease progresses from microscopic hematuria (microhematuria) to proteinuria, progressive renal insufficiency, and end-stage renal disease (ESRD) in all males with XLAS, and in all males and females with ARAS. Progressive sensorineural hearing loss (SNHL) is usually present by late childhood or early adolescence. Ocular findings include anterior lenticonus (which is virtually pathognomonic), maculopathy (whitish or yellowish flecks or granulations in the perimacular region), corneal endothelial vesicles (posterior polymorphous dystrophy), and recurrent corneal erosion. In individuals with ADAS, ESRD is frequently delayed until later adulthood, SNHL is relatively late in onset, and ocular involvement is rare.</Attribute>
                <XRef ID="NBK1207" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="624" />
                <XRef ID="624" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301386</ID>
                <ID Source="BookShelf">NBK1207</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGentest, 2011">
                <ID Source="PubMed">22166944</ID>
              </Citation>
              <XRef ID="63" DB="Orphanet" />
              <XRef ID="88918" DB="Orphanet" />
              <XRef ID="C5882663" DB="MedGen" />
              <XRef ID="MONDO:0007086" DB="MONDO" />
              <XRef Type="MIM" ID="104200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="4888007" SubmissionDate="2024-04-12" DateLastUpdated="2024-04-15" DateCreated="2022-04-12">
        <ClinVarSubmissionID localKey="rmh/unit_1/hg38_NM_000092_5_COL4A4_c_4760dupC" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002498629" DateUpdated="2024-04-15" DateCreated="2022-04-12" Type="SCV" Version="2" SubmitterName="Molecular Genetics, Royal Melbourne Hospital" OrgID="508231" OrganizationCategory="laboratory" OrgAbbreviation="RMH" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">20301386</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30745910</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33772369</ID>
          </Citation>
          <Comment>This sequence change in COL4A4 is a frameshift variant predicted to cause a premature stop codon (p.(Cys1588Metfs*46)) that is predicted to escape nonsense mediated decay and remove &lt;10% of the protein in a gene where loss-of-function is an established disease mechanism (PMID: 20301386). This variant is present in a single individual in gnomAD v3.1 (1/41,444 alleles) in the African/African American population. This variant has been detected in at least two individuals compound heterozygous for the variant and a pathogenic or likely pathogenic variant with Alport syndrome (PMID: 30745910, 33772369). Based on the classification scheme RMH Modified ACMG Guidelines v1.4.0, this variant is classified as LIKELY PATHOGENIC. Following criteria are met: PM3_Strong, PVS1_Moderate, PM2_Supporting.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_7959</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000092.5:c.4760dupC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0007086" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_41</SubmissionName>
          <SubmissionName>submission_9</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8339329" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2024-02-20">
        <ClinVarSubmissionID localKey="6400670|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004551535" DateUpdated="2024-02-20" DateCreated="2024-02-20" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-03-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26809805</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30745910</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33772369</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the COL4A4 protein in which other variant(s) (p.Cys1683Tyr) have been determined to be pathogenic (PMID: 26809805; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. ClinVar contains an entry for this variant (Variation ID: 1676233). This premature translational stop signal has been observed in individual(s) with autosomal recessive Alport syndrome (PMID: 30745910, 33772369). This variant is present in population databases (no rsID available, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Cys1588Metfs*46) in the COL4A4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 103 amino acid(s) of the COL4A4 protein.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="COL4A4" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.227872782_227872783insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200314</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4888007" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0007086" MappingRef="MONDO">
        <MedGen CUI="C5882663" Name="Autosomal dominant Alport syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8339329" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

